Latest International Growth News

Pure Hydrogen Corporation reported FY2025 revenue growth alongside a significant non-cash impairment charge, while progressing its clean hydrogen vehicle technologies and planning a spinout of its Australian gas assets.

Orthocell has appointed its first Canadian distributor for Remplir, its innovative nerve repair device, ahead of an official launch at a major surgical conference in Vancouver. The move marks a significant step in expanding the product’s international footprint.

Vection Technologies reports a 60% revenue surge in 1H25, secures a $21 million equity raise, and strengthens its position in defence AI and spatial computing with a robust $75 million sales pipeline.

Premier Investments reported a 31% jump in net profit to $338.2 million for FY25, driven by the sale of Just Group and a $1.03 billion fully franked In-Specie Distribution to shareholders. Continuing operations showed a profit decline amid strategic brand investments.

Decidr AI Industries has successfully completed a $20 million placement, positioning itself to accelerate international growth and advance its AI technology platform.

Epsilon Healthcare’s manufacturing arm has secured updated GMP certificates covering domestic and EU/UK markets, reinforcing its quality credentials and paving the way for expanded international contract manufacturing.

Spacetalk Ltd has raised $4.05 million through a combination of a conditional placement and convertible notes to accelerate its geographic expansion and app development, alongside appointing a seasoned director to its board.

Bioxyne Limited has secured import permits and purchase orders worth A$5.1 million for medical cannabis in Germany, signaling strong early traction in a key European market.

Prophecy International Holdings Ltd has announced the immediate resignation of CEO Brad Thomas, with Chairman Ed Reynolds stepping in as acting CEO during the leadership transition.

My Rewards International Limited has announced a pro-rata entitlement offer aiming to raise up to $4.1 million, a key step toward meeting ASX reinstatement conditions after a prolonged trading suspension. The offer includes a debt conversion proposal and is partially underwritten by major shareholders.

Red Sky Energy has formalized its 35% interest in Angola’s Block 6/24 following parliamentary ratification of the Risk Service Contract, unlocking access to significant oil resources and advancing its international growth strategy.

Biome Australia has partnered with Green Cross Health to launch its Activated Probiotics across New Zealand’s largest pharmacy network, marking a pivotal step in its international growth strategy.